Try our Advanced Search for more refined results
Life Sciences - November, 2008
145 articles
- Complaints On Wyeth Outsourcing Led To Firing: Suit
- NationsHealth Workers Launch Unpaid Wage Action
- Lilly Shoots Off 2 More Cymbalta Suits
- Barr, Mylan Face Patent Suit Over Amrix ANDAs
- Melamine Traces Found In US Baby Formula
- Avandia Bigger Heart Risk Than Competitor: Study
- StarCaps Diet Pill Recalled For Unauthorized Diuretic
- Vaginal Deformity Claims To Proceed Against AMS
- Aredia Judge Tosses More Failure-To-Warn Claims
- J&J E-mails Link Research Center, Risperdal
- FDA Tells Cedax Maker To Fix Deceptive Marketing
- Minn. Supreme Court To Weigh In On Prempro MDL
- Roche, Apotex Drop One Patent In Spat Over Boniva
- Magistrate Rules On Motions In Crestor Patent MDL
- EU Report To Target Drug Patents, Lawsuits
- Bayer Pays $97.5M To Settle Kickback Allegations
- EU Raids Drug Cos. In Latest Antitrust Sting
- AstraZeneca Settles Pulmicort War With Teva
- Abbott, WARF Clash With Teva Over Zemplar
- Texas Eastern District: IP Equipoise?
- Lane Powell Ordered Off CellCyte Investor Suit
- GSK Parent Off The Hook In Paxil Birth Defect Suit
- Barr Settles With CVS, Walgreen But Not Meijer
- Officials Warn Of Deaths Linked To Bayer Drug
- Obama Could Raise Cap On H-1B Skilled Workers
- Medtronic Loses Jury Trial Bid In Defibrillator Suit
- PharmaNet Stock Plunge Prompts Class Action
- FDA Warns Of Epilepsy Drug Danger For Asians
- Quigley Urges Court To Overrule Insurance Protests
- Pfizer Wins Choice-Of-Law Appeal In Lipitor Actions
- Fed. Circ. Reverses Ruling In IV Patent Dispute
- McKesson Agrees To Settle AWP Case For $350M
- Calif. Supreme Court To Consider 'Pass-On' Defense
- GSK Ordered To Produce Paxil Ad Campaign Details
- Bracing For The Surge In Reimbursement Disputes
- Avastin-Chemo Combo Could Boost Clot Risk: Study
- Under Obama, IP Reforms May Still Come Slow
- Abbott Settles TriCor Class Action For $184M
- Eli Lilly, Princeton Fire Off Another Alimta Suit
- Roche Vows To Appeal $12.9M Accutane Verdict
- Sanofi Victorious In Arava Antitrust Class Action
- Court Reverses Obviousness Ruling In Andersen Case
- AstraZeneca Scores TRO Against Teva
- SEC Sues Traders Over Alleged Short-Sale Scheme
- Arthrex Hit With Injunction In Suture Anchor Suit
- Anticipating Obama's Consumer Protection Push
- General Growth Hires Sidley Austin Bankruptcy Attys.
- EU Calls For Suspension Of J&J's Ionsys
- Lilly Targets Actavis In Latest Cymbalta Patent Suit
- 1st Circ. Upholds NH Law On Prescription Data
- 'Straw Dogs' Unlikely To Doom Obama AG Nominee
- Novartis Spars With Sales Reps Over FLSA Exemptions
- Marriott Timeshare Salesman Sues For Overtime Pay
- Boehringer Sues To Block Norbrook's Generic Metacam
- Wyeth, Cordis Add Abbott To Medtronic Stent Spat
- Pa. Names Former GE Plant Hazardous Waste Site
- AstraZeneca, Teva Patent Spat Flares Up
- FDA Opens 3 Offices In China
- Sanofi To Get $60M In Allegra Deal With Barr, Teva
- Sun Pharma Fires Back At Biovail In Cardizem Suit
- Nev. Sues Wyeth, Pfizer Over Hormone Drugs
- Wyeth Asks For Delay In Patent Fight With Apotex
- DOJ Subpoenas Medtronic Over Bone Graft Product
- Schering Sues Sun, Caraco Over New Clarinex Patent
- Eli Lilly Circles Wagons Around Cymbalta Patent
- Alpharma Sues Purdue Over Painkiller Mktg. Rights
- 5th Circ. Rebuffs Insurers In Vioxx Settlement
- Jury Tags J&J Units To Pay $16M For Pain Patch Death
- Plavix: A Significant Decision For Patent Holders
- Pfizer Seeks To Limit Discovery In Quigley Ch. 11
- Pozen Sues Par Pharmaceutical Over Migraine ANDA
- Teva, Zydus Drop Some Claims In Coreg Patent Suit
- DOJ Takes Aim At Actavis' Drug-Making Practices
- Teva Contests 2 Of Gilead's Truvada Patents
- The 'Substantial Question Of Patentability' Defense
- Lawmakers Probe FDA Over Medical Device Review
- GSK Wins Bid To Boot Paxil Suicide Suit
- FDA Seeks Panel Expert Review Of Antibiotic
- Univ. Of Kansas Sues NIH Over Cancer Drug Patents
- Leaps and Bounds: Notable Firm News
- SEC Charges Ex-McKesson Exec With Insider Trading
- 4 Novartis Claims Dropped In Retisert Sales Spat
- Synthes Brandishes Patent Against Implant Maker
- Hotbed Of FLSA Claims To Continue In Low Economy
- EU Raids French Biomedical Analysis Firms
- US Attorneys' Offices' Resources Mismanaged: Audit
- Patent Litigation Evolves Slowly In Shaky Economy
- McKesson Manager Disgorges Insider Trading Spoils
- Orion Strikes At Sun Over Comtan ANDA
- Roche, Mutual Drop Part Of Suit Over Boniva
- Tort Victims Challenge Privilege In Quigley Ch. 11
- Bone Drugs Pose No Clear Threat To Heart: FDA
- Beleaguered Mall Owner Weighs Bankruptcy
- In Perspective: Federal Agency Standards Preemption
- FDA Eyes Alpharma's Embeda Over Abuse Effects
- Woman Slaps Pfizer With Lawsuit Over PCBs
- CR Bard Falls Short In Bid To Nullify Class
- Drug Co. Sues USPTO Over Patent Term Adjustment
- Forest Labs To Settle Shareholders' Suit For $65M
- A Broader Scope For American Pipe Tolling Doctrine
- Accentia Seeks Ch. 11 Shelter, Blames Credit Crunch
- Katz Inks Licensing Deals With 10 More Cos.
- Mo. Right Venue For Teva Amoxicillin Suit: Judge
- Looking At The Future Of Preemption
- Hope At Last For Drug Manufacturers Sued In NJ?
- Sedgwick Acquires Ft. Lauderdale Law Firm
- Consolidated 3rd-Party Payer Seroquel Case Tossed
- Ethex Issues Another Recall Of Oversize Pills
- SRU's 31 Sensor Patents Invalid, Sensor Maker Claims
- Teva Hears No Again In Risperdal Spat
- Court Denies Lilly Depositions In Zyprexa MDL
- Baltimore Targets McKesson For AWP Markups
- Wyeth Can Be Liable For Generic Warnings: Court
- Teva's Bid To Crack Attorney-Client Privilege Fails
- Obama's FDA Commissioner Pick Could Be Outsider
- Wyeth, Pfizer Face More Claims In Premarin Suit
- Fed. Circ. Upholds Bar On Generic Prevacid For Teva
- Innovator's Guide To Navigating CMS
- Bayer Sues Norbrook Over Bid For Livestock Drug
- 471,000 Mislabeled Insulin Syringes Recalled
- Baby Formula Makers' Case Transfer Request Denied
- Wyeth Settles With 4th Drug Co. Over Generic Effexor
- Asbestos Victims Demand Voice In Quigley Case
- FDA Takes Contaminated Heparin From Ohio Drug Co.
- Willfulness Claims Stricken In 4 ADHD Drug Suits
- Impax Sued Again Over Ultram ANDA
- Canada High Court Upholds Plavix 'Selection' Patent
- FDA Enforcement May Soon Extend To Tobacco
- Former Goldman Analyst May Have Fled US
- Calif. Fertility Clinic Hit With FDA Warning
- US Airways Settles De-Icer Product Liability Suit
- Judge: Corepharma Did Not Infringe Carbatrol Patent
- DOJ, State AGs Investigate Vytorin Marketing
- FDA Warns Caraco Over Violations At Drug Plant
- 9th Circ. Denies Dismissal To HBOC Fraud Defendants
- Plaintiff Bid To Disband Baycol MDL Nixed
- Abbott Sues Biovail Over Generic TriCor
- Genetic Researchers Clash Over Diagnostic Patents
- Cephalon Sues Barr Again Over Generic Fentora ANDA
- Future Product Liability Law In Hands Of High Court
- Roche Wins Judgment In Accutane Suicide Case
- Sheppard Mullin Lands 13th Heller Partner For Year
- DOJ Eyes AtriCure Over Marketing Practices
- Wyeth V. Levine In Light Of Merck's Vioxx Litigation
- Omnicare Faces 2 Qui Tam Antitrust Fraud Suits